Lance Wilkes
Stock Analyst at Bernstein
(2.31)
# 2,488
Out of 4,842 analysts
26
Total ratings
50%
Success rate
10.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lance Wilkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOH Molina Healthcare | Initiates: Outperform | $414 | $302.09 | +37.05% | 1 | Apr 22, 2025 | |
| AGL agilon health | Initiates: Market Perform | $2.5 | $2.31 | +8.23% | 1 | Dec 11, 2024 | |
| CNC Centene | Maintains: Outperform | $96 → $88 | $56.22 | +56.53% | 4 | Oct 30, 2024 | |
| HUM Humana | Upgrades: Outperform | $308 | $230.12 | +33.85% | 3 | Oct 8, 2024 | |
| HCA HCA Healthcare | Downgrades: Market Perform | $301 | $384.00 | -21.61% | 4 | Jan 4, 2024 | |
| CI The Cigna Group | Upgrades: Outperform | $372 | $311.12 | +19.57% | 6 | Jan 4, 2024 | |
| UNH UnitedHealth Group | Upgrades: Outperform | $595 → $603 | $301.68 | +99.88% | 4 | Jul 18, 2023 | |
| CVS CVS Health | Maintains: Market Perform | $107 → $93 | $62.95 | +47.74% | 3 | May 2, 2023 |
Molina Healthcare
Apr 22, 2025
Initiates: Outperform
Price Target: $414
Current: $302.09
Upside: +37.05%
agilon health
Dec 11, 2024
Initiates: Market Perform
Price Target: $2.5
Current: $2.31
Upside: +8.23%
Centene
Oct 30, 2024
Maintains: Outperform
Price Target: $96 → $88
Current: $56.22
Upside: +56.53%
Humana
Oct 8, 2024
Upgrades: Outperform
Price Target: $308
Current: $230.12
Upside: +33.85%
HCA Healthcare
Jan 4, 2024
Downgrades: Market Perform
Price Target: $301
Current: $384.00
Upside: -21.61%
The Cigna Group
Jan 4, 2024
Upgrades: Outperform
Price Target: $372
Current: $311.12
Upside: +19.57%
UnitedHealth Group
Jul 18, 2023
Upgrades: Outperform
Price Target: $595 → $603
Current: $301.68
Upside: +99.88%
CVS Health
May 2, 2023
Maintains: Market Perform
Price Target: $107 → $93
Current: $62.95
Upside: +47.74%